CLASS II Device recall · Reported 25 Dec 2013 · FDA Enforcement Report

FastPack Total PSA Immunoassay Chemilunescence assay recalled

Qualigen is recalling FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA, distributed in 16 states. The recall was initiated on 8 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesTotal PSA: Catalog Number 25000040. Lot Number 1309038-10P Exp Date 6/26/2013.
Quantity recalled182

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0547-2014
FDA event ID
66842
Recalling firm
Qualigen, Carlsbad, CA
Classification
Class II
Status
Terminated
Recall initiated
8 Nov 2013
FDA classified
19 Dec 2013
Reported
25 Dec 2013
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Device Malfunction

Timeline

8 Nov 2013Recall initiated by company
19 Dec 2013Classified by FDA+41 days
25 Dec 2013Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack Total PSA Immunoassay is designed for use with the FastPack System.

Where it was distributed

US Distribution to states of: AL, CA, KS, KY, IN, MA, NC, NY, NV, OK, SC, TN, TX, UT, VA, and WA.

AlabamaCaliforniaIndianaKansasKentuckyMassachusettsNorth CarolinaNevadaNew YorkOklahomaSouth CarolinaTennesseeTexasUtahVirginiaWashington

Questions about this recall

Why was it recalled?

Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Which lots are affected?

Total PSA: Catalog Number 25000040. Lot Number 1309038-10P Exp Date 6/26/2013.

Where was it sold?

US Distribution to states of: AL, CA, KS, KY, IN, MA, NC, NY, NV, OK, SC, TN, TX, UT, VA, and WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 66842

This product is part of a recall event; the main page for the event is FastPack Free T4 Immunoassay FastPack Vitamin D Immunoassay recalled.

More recalls from Qualigen

All 8

Other Test Kits & Diagnostics recalls

All 2,675
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IINextseq 550Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IINovaSeq 6000Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IILiaison Plex Gram-Negative Blood Culture Assay recalled by LuminexLuminexPotency & AssayNationwide
DeviceCLASS IIMiSeq Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IITechno-Path Multichem AE Unassayed Level recalledTechno-path ManufacturingPotency & AssayNationwide